Home » Newsletters » BioWorld Science

BioWorld Science

March 9, 2020

View Archived Issues

Chimeric BET degrader-antibody conjugate shows improved PK and in vivo antitumor activity

Health Canada approves phase I study of Cardiol's ultra-pure CBD formulation

EMILIN3 and INA identified as novel markers of LG-ESS using comparative proteomics

11beta-HSD1 as a new marker of response to IC blockade therapy in NSCLC

Mutations in PIK3-ATK-MTOR pathway linked to poor prognosis in oligodendrogliomas

Rapamycin, telomeres have unexpectedly complex relationship

Serine improves memory in Alzheimer's mouse model

From junk to noncoding to coding

Adipophilin tied to poor prognosis in malignant melanoma

Asceneuron patents new OGA inhibitors

Shanghai Allist Pharmaceutical discloses EGFR mutant inhibitors

Nanjing TransThera Biosciences identifies TAM family kinases inhibitors

CytoDyn submits IND application to study leronlimab for COVID-19 respiratory complications

Algernon makes ifenprodil available for compassionate use for coronavirus

ALRN-6924 upregulates P21 expression in AML/MDS patients

FDA approves Isturisa for Cushing's disease

Compugen releases new data from phase I study of COM-701 in advanced solid tumors

Netherlands Cancer Institute plans phase I/Ib study of RMC-4630 with ERK inhibitor

Ascentage cleared to begin new trials of APG-2575 in U.S. and China

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...